Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase

Launched by CENTRE FRANCOIS BACLESSE · Feb 7, 2023

Keywords

ClinConnect Summary

This clinical trial, called AFTERGYN, is focused on understanding and improving the support needs of women who have completed treatment for ovarian or endometrial cancer. The researchers aim to evaluate what kind of supportive care these patients require after their treatment and how to organize this care effectively. By doing so, they hope to enhance the follow-up care these patients receive and ultimately improve their quality of life in the long term.

To participate in this trial, women must be over 18 years old and in complete remission after their first treatment for endometrial or ovarian cancer. They should have finished their initial treatment, but those on maintenance therapies can still join. It’s important that participants can speak French and have access to a telephone. The study excludes individuals with certain medical or psychiatric conditions that might affect their ability to take part, as well as those whose cancer has returned. If you join, you can expect to share your experiences and needs regarding post-cancer care, contributing to a better understanding of how to support others in similar situations.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patient \> 18 years old
• • Patient in complete remission after first-line treatment for endometrial or ovarian/fallopian tube/peritoneal cancer
• • Patient having completed her initial treatment; patients with maintenance treatments are eligible
• • Mastery of the French language
• • Patient with a telephone line
• • Patient affiliated to a social security scheme
• • Signature of informed consent before any specific procedure related to the study
• Exclusion Criteria:
• • Any associated medical or psychiatric conditions that could compromise the patient's ability to participate in the study
• • Patient with locoregional or metastatic recurrence
• • Patient deprived of liberty, under guardianship or curatorship
• • Simultaneous participation in a therapeutic clinical trial